REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF THE COUNTY OF SAN BERNARDINO
AND RECORD OF ACTION
May 19, 2020
FROM
WILLIAM L. GILBERT, Director, Arrowhead Regional Medical Center
SUBJECT
Title v
Amendment to Agreement with INO Therapeutics LLC, dba Mallinckrodt, for the Provision of INOtherapy Services
End
RECOMMENDATION(S)
Recommendation
Approve Amendment No. 1 to Contract No. 4400012056 with INO Therapeutics LLC, dba Mallinckrodt ("Mallinckrodt"), to extend the contract period through May 31, 2021, for total contract period of June 1, 2019, through May 31, 2021, and increase the contract amount by $77,664, for a total contract amount of $161,992, for the provision of INOtherapy services.
(Presenter: William L. Gilbert, Director, 580-6150)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of this item will not result in the use of Discretionary General Funding (Net County Cost). The additional cost of $77,664 is funded by State Medi-Cal, Federal Medicare, private insurances, and other departmental revenue. Funding sources may change in the future pending any legislative activity related to the repeal and/or replacement of the Affordable Care Act. Adequate appropriation and revenue have been included in the Arrowhead Regional Medical Center (ARMC) 2019-20 budget and will be included in future recommended budgets.
BACKGROUND INFORMATION
Approval of this Item will allow ARMC to continue receiving INOtherapy services from Mallinckrodt, which consists of the pharmaceutical drug INOMAX (r) (nitric oxide) for inhalation and the delivery devices needed to administer the drug. The INOtherapy services will be used at the Neonatal Intensive Care Unit (NICU) at ARMC. Inhaled nitric oxide is a specific pulmonary medication that dilate blood vessels. It affects the muscles in the walls of the arteries and veins, preventing the mus...
Click here for full text